(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

GENESIS BIOTECHNOLOGY GROUP

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

GENESIS BIOTECHNOLOGY GROUP

ST13

US500000085013557

Classe

42

Pedido

85013557

Registro

4462943

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

60

Atualização mais recente

15/09/2023

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

42

Data de depósito

14/04/2010

Data de registro

07/01/2014

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

14/09/2023

Última transação

15/09/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

08/03/2011

Primeiro uso no comércio

08/03/2011

Código do desenho

3

Tipo de titular

16

Localização do titular

HAMILTON, NJ

Examinador

KEARNEY, COLLEEN

Unidade examinadora

M40

Localização atual

GENERIC WEB UPDATE

Descrição da marca

The mark consists of the stylized term "GENESIS" above the phrase "BIOTECHNOLOGY GROUP" with a sylized depiction of a molecule consisting of fourteen spheres representing atoms that are connected by straight bands representing bonds wherein the letter "I" in "GENESIS" is represented by a vertical band connecting two atoms; the color maroon appears in the letters "GENES" and "S" in "GENESIS"; the color beige appears in the fourteen spheres representing atoms; the color black appears in the phrase "BIOTECHNOLOGY GROUP", in the letter "I" in "GENESIS" and in the straight lines representing bonds; the color white appears in the shading of the atoms.

Titulares e representantes

Titulares

GENESIS BIOTECHNOLOGY GROUP, LLC
Medical Diagnostic Laboratories, LLC

Representantes

Christina E. Brule Heslin Rothenberg Farley & Mesiti P.C.

Classificação técnica

Classes Nice

Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Research and development in the pharmaceutical and biotechnology fields specifically relating to molecular diagnosticssuch asPolymerase Chain Reactionscancer researchsuch ascervicalbladder and prostate cancerswomen's health researchsuch asbacterial vaginosisherpes simplex virushuman papillomavirusgonorrheabiomarker and novel drug discoverysuch ashigh throughput screening of new chemical compoundsimmunology abnormalitysuch asirritable bowel disease and Crohn's diseaseantimicrobials researchall of the foregoing goods and services excluding waste treatment and the treatment of waste in the marine industry

Publicações

Histórico de despachos e eventos da marca no USPTO.

60 publicações encontradas

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

15/09/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/09/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/09/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/09/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

14/09/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

14/09/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

14/09/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

14/09/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

06/03/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/01/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

07/02/2019

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/02/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/02/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/01/2019

E815

TEAS SECTION 8 & 15 RECEIVED

08/01/2019

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/01/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

07/01/2014

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

06/12/2013

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

05/12/2013

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/12/2013

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/11/2013

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/11/2013

IUAF

USE AMENDMENT FILED

02/10/2013

EISU

TEAS STATEMENT OF USE RECEIVED

02/10/2013

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

20/08/2013

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/06/2013

PUBO

PUBLISHED FOR OPPOSITION

25/06/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/06/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

22/05/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

15/05/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

15/05/2013

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

15/05/2013

GNEA

EXAMINERS AMENDMENT E-MAILED

15/05/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

15/05/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/04/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

24/04/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

24/04/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

24/10/2012

GNRT

NON-FINAL ACTION E-MAILED

24/10/2012

CNRT

NON-FINAL ACTION WRITTEN

24/10/2012

DOCK

ASSIGNED TO EXAMINER

01/10/2012

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

26/09/2012

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

23/03/2012

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

18/09/2011

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

16/03/2011

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/09/2010

GNSL

LETTER OF SUSPENSION E-MAILED

10/09/2010

CNSL

SUSPENSION LETTER WRITTEN

10/09/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/08/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/08/2010

ALIE

ASSIGNED TO LIE

17/08/2010

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/08/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/08/2010

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

26/07/2010

GNRT

NON-FINAL ACTION E-MAILED

26/07/2010

CNRT

NON-FINAL ACTION WRITTEN

26/07/2010

DOCK

ASSIGNED TO EXAMINER

21/07/2010

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

20/04/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

19/04/2010

NWAP

NEW APPLICATION ENTERED

17/04/2010

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace GENESIS BIOTECHNOLOGY GROUP ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.